Evidence map›Paper›PMID 30108193›Full record

ReviewThe Journal of clinical investigation2018

Role of sphingolipids in senescence: implication in aging and age-related diseases.

Magali Trayssac, Yusuf A Hannun, Lina M Obeid

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 195 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Sphingolipids in Emotional Well-Being.Journal of neurochemistry · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Magali TrayssacStony Brook Cancer Center and Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
Yusuf A HannunStony Brook Cancer Center and Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
Lina M ObeidStony Brook Cancer Center and Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
Northport VA Medical Center · US

Funding

Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI YUSUF AWNI HANNUN · 2003 to 2026
$30.8M
Neutral Sphingomyelinases and Bioactive CeramidesR35GM118128 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI HANNUN, YUSUF AWNI · 2016 to 2025
$7.9M
Role and Regulation of Ceramide Synthases in ApoptosisR01GM097741 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI LUBERTO, CHIARA · 2011 to 2019
$3.5M
NCI NIH HHS P01 CA097132NIGMS NIH HHS R01 GM097741NIGMS NIH HHS R35 GM118128
6 · The paper itself

Abstract

Aging is defined as the progressive deterioration of physiological function with age. Incidence of many pathologies increases with age, including neurological and cardiovascular diseases and cancer. Aging tissues become less adaptable and renewable, and cells undergo senescence, a process by which they "irreversibly" stop dividing. Senescence has been shown to serve as a tumor suppression mechanism with clear desirable effects. However, senescence also has deleterious consequences, especially for cardiovascular, metabolic, and immune systems. Sphingolipids are a major class of lipids that regulate cell biology, owing to their structural and bioactive properties and diversity. Their involvement in the regulation of aging and senescence has been demonstrated and studied in multiple organisms and cell types, especially that of ceramide and sphingosine-1-phosphate; ceramide induces cellular senescence and sphingosine-1-phosphate delays it. These discoveries could be very useful in the future to understand aging mechanisms and improve therapeutic interventions.

Indexed as

AgingAlzheimer DiseaseAnimalsAtherosclerosisBiomarkersCellular SenescenceCeramidesDiabetes Mellitus, Type 2HumansImmune SystemLysophospholipidsMetabolic Networks and PathwaysModels, BiologicalNeoplasmsSphingolipidsSphingosineBiomarkersCeramidesLysophospholipidsSphingolipidsSphingosinesphingosine 1-phosphate

Identifiers

PMID30108193
PMCPMC6025964
OpenAlexW2809905001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.